NGEN
Nervgen Pharma
$1.50
+$0.02 (+1.35%)Oct 28, 2026
Key metrics
The numbers that frame NGEN today
- Market cap
- $159.62M
- ROIC
- 76.6%
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for NGEN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NGEN
Is Nervgen Pharma a good buy?
No. Nervgen Pharma has poor quality. Growth looks poor. That could put pressure on the long-term business case. We think Nervgen Pharma is selling at a very high price.
What is the market capitalization of NGEN?
Nervgen Pharma's market capitalization is $159.62M.
Does NGEN stock pay dividends?
Nervgen Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NGEN?
Nervgen Pharma's Debt / Equity ratio is 0.